Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-21

Clinical Trial Update: CANA/Met in Non-diabetic Women With PCOS [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating CANA/Met in non-diabetic women with polycystic ovary syndrome (PCOS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CANA/Met

Snippet

Sponsor: Shengjing Hospital | Conditions: Polycystic Ovary Syndrome | Phase 1, Phase 2 | Status: COMPLETED